Potassium Citrate

Potassium Citrate

Snapshot

Potassium Citrate is a potassium salt of citric acid that supports alkalinization of urine, kidney stone prevention, and electrolyte balance.

ย 


What is Potassium Citrate?

Potassium Citrate (Kโ‚ƒCโ‚†Hโ‚…Oโ‚‡) dissociates into potassium ions and citrate anions, which increase urinary pH and citrate concentration, reducing urinary supersaturation of calcium salts.


Where It Comes From

Pharmaceuticalโ€‘grade Potassium Citrate is synthesized by neutralizing citric acid with potassium hydroxide, followed by crystallization and drying into a fine, white powder or tablet form.


Key Nutrients & Compounds

Delivers potassium for electrolyte homeostasis and citrate, a key inhibitor of calcium crystallization in the urinary tract, promoting urine alkalinization.


Health Benefits

Potassium Citrate prevents kidney stone formation, especially calcium oxalate stones; treats metabolic acidosis; and helps maintain systemic acidโ€‘base balance while supplying essential potassium.


Recommended Dosage

Typical doses range from 10 to 30โ€ฏmEq of potassium citrate (approx. 1โ€“3โ€ฏg) taken two to three times daily with meals; dosing adjusted based on urinary pH and physician guidance.


How to Use It

Take tablets or powder dissolved in water or juice with meals to improve gastrointestinal tolerance; monitor urine pH (target 6.5โ€“7.0) to guide dosing.


Who Should Use It?

Individuals with recurrent calcium kidney stones, metabolic acidosis, or low urinary citrate levels; use under nephrology or urology specialist supervision.


Possible Interactions or Cautions

Use caution in hyperkalemia or renal impairment; avoid concomitant use with potassiumโ€‘sparing diuretics; monitor serum potassium levels regularly.


Final Thoughts

Potassium Citrate is an effective intervention for stone prevention and acidโ€‘base management, combining electrolyte replenishment with urinary alkalinization.


Scientific Studies

Preminger GM, et al. Potassium citrate therapy in recurrent stone formers: reduced supersaturation and stone formation. J Urol. 1990;143(3):376โ€“379. https://doi.org/10.1016/S0022-5347(17)38418-3

Tiselius HG, et al. Role of citrate in urine stone disease. Kidney Int. 2003;64(6):2262โ€“2267. https://doi.org/10.1046/j.1523-1755.2003.00230.x

Barcelo P, et al. Longโ€‘term treatment with potassium citrate in recurrent stone formers. J Urol. 1993;149(6):1537โ€“1540. https://doi.org/10.1016/S0022-5347(17)36467-4